The overall ratings of 7 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Allergan plc (AGN) slips from a C to a D this week. Allergan plc is a healthcare company focused on developing and commercializing pharmaceuticals, biologics, and medical devices. For more information, get Portfolio Grader’s complete analysis of AGN stock.
This week, Perrigo Co. Plc’s (PRGO) rating worsens to a F from the company’s D rating a week ago. Perrigo Co. Plc manufactures, distributes and markets pharmaceutical and nutritional products. The company also gets F’s in operating margin growth and earnings growth. For more information, get Portfolio Grader’s complete analysis of PRGO stock.
This week, Mylan N.V. (MYL) drops from a C to a D rating. Mylan N.V. is a global generic and specialty pharmaceuticals company. For more information, get Portfolio Grader’s complete analysis of MYL stock.
Dr. Reddy’s Laboratories Ltd. Sponsored ADR (RDY) experiences a ratings drop this week, going from last week’s C to a D. Dr. Reddy’s Laboratories Ltd. Sponsored ADR is a global company that produces and markets active pharmaceutical ingredients, intermediates, finished dosage forms, and biologic products. For more information, get Portfolio Grader’s complete analysis of RDY stock.
Concordia Healthcare Corp. (CXRX) is having a tough week. The company’s rating falls from a D to a F. The company also gets F’s in operating margin growth, earnings growth, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of CXRX stock.
Assembly Biosciences, Inc.’s (ASMB) rating weakens this week, dropping to a F versus last week’s D. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of ASMB stock.
Slipping from a C to a D rating, Merus Labs International Inc. (MSLI) takes a hit this week. Merus Labs International Inc. acquires and licenses niche branded pharmaceutical products in the United States and Canada. For more information, get Portfolio Grader’s complete analysis of MSLI stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
